Randall B. Brenner - 17 Sep 2019 Form 3/A - Amendment Insider Report for Paratek Pharmaceuticals, Inc.

Role: Chief Development & Regulatory
Signature: /s/ William M. Haskel, Attorney-in-Fact for Randall B. Brenner
Issuer symbol: N/A
Transactions as of: 17 Sep 2019
Net transactions value: $0
Form type: 3/A - Amendment
Filing time: 06 Jun 2023, 18:37:47 UTC
Date Of Original Report: 27 Sep 2019
Next filing: 08 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	PRTK	Common Stock						25,000	17 Sep 2019	Direct	F1
holding	PRTK	Common Stock						15,000	17 Sep 2019	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were omitted from the Reporting Person's original Form 3, and were also omitted from subsequent Form 4s filed by the Reporting Person after his original Form 3 was filed. Represents performance-based restricted stock units ("PRSUs") granted on August 3, 2017 to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan, which were earned on October 2, 2018. These PRSUs settled in shares of Common Stock on October 2, 2019.
F2	These shares were omitted from the Reporting Person's original Form 3, and were also omitted from subsequent Form 4s filed by the Reporting Person after his original Form 3 was filed. Represents PRSUs granted on February 14, 2018 to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan, which were earned on February 1, 2019. These PRSUs settled in shares of Common Stock on May 8, 2020.

Content

These shares were omitted from the Reporting Person's original Form 3, and were also omitted from subsequent Form 4s filed by the Reporting Person after his original Form 3 was filed. Represents performance-based restricted stock units ("PRSUs") granted on August 3, 2017 to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan, which were earned on October 2, 2018. These PRSUs settled in shares of Common Stock on October 2, 2019.

These shares were omitted from the Reporting Person's original Form 3, and were also omitted from subsequent Form 4s filed by the Reporting Person after his original Form 3 was filed. Represents PRSUs granted on February 14, 2018 to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan, which were earned on February 1, 2019. These PRSUs settled in shares of Common Stock on May 8, 2020.